Negative Epistasis between Sickle and Foetal Haemoglobin Suggests a Reduction in Protection against Malaria
Open accessThe DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Haemoglobin variants, Sickle (HbS) and foetal (HbF) have been associated with malaria protection. This study explores epistatic interactions between HbS and HbF on malaria infection. METHODS: The study was conducted between March 2004 and December 2013 within the sickle cell disease (SCD) programme at Muhimbili National Hospital, Tanzania. SCD status was categorized into HbAA, HbAS and HbSS using hemoglobin electrophoresis and High Performance Liquid Chromatography (HPLC). HbF levels were determined by HPLC. Malaria was diagnosed using rapid diagnostic test and/or blood film. Logistic regression and generalized estimating equations models were used to evaluate associations between SCD status, HbF and malaria. FINDINGS: 2,049 individuals with age range 0-70 years, HbAA 311(15.2%), HbAS 241(11.8%) and HbSS 1,497(73.1%) were analysed. At enrolment, malaria prevalence was significantly higher in HbAA 13.2% compared to HbAS 1.24% and HbSS 1.34% (p<0.001). Mean HbF was lower in those with malaria compared to those without malaria in HbAA (0.43% vs 0.82%) but was the reverse in HbSS (8.10% vs 5.59%). An increase in HbF was associated with a decrease in risk of malaria OR=0.50 (95%CI: 0.28, 0.90; p=0.021) in HbAA, whereas for HbSS the risk of malaria increased OR=2.94 (1.44, 5.98; p=0.003). A similar pattern was seen during multiple visits; HbAA OR=0.52 (0.34, 0.80; p=0.003) vs HbSS OR=2.01 (1.27, 3.23; p=0.003). CONCLUSION: Higher prevalence of malaria in HbAA compared to HbAS and HbSS confirmed the protective effect of HbS. Lower prevalence of malaria in HbAA with high HbF supports a protective effect of HbF. However, in HbSS, the higher prevalence of malaria with high levels of HbF suggests loss of malaria protection. This is the first epidemiological study to suggest a negative epistasis between HbF and HbS on malaria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HbF did not provide protection from malaria in African (HbF, 5.6%) or Indian (HbF, 18.2%) sickle cell anemia patients.71,72”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [71]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 1×
“In individuals with HbSS, the level of HbF is variable but may reach 20%, with high levels of HbF associated with amelioration of disease severity [7].”
BackgroundPopulation and Housing Census.
Tobago (2011) · Cited by 1,384
Protection Afforded by Sickle-cell Trait Against Subtertian Malarial Infection
Allison, A. C. (1954) · BMJ · doi:10.1136/bmj.1.4857.290 · Cited by 1,291 · cited 2×
“For HbS, we confirmed previous observations [1,2] that the prevalence of malaria in individuals with HbAS and HbSS was lower compared to those with HbAA.”
BackgroundResultPiel, F. B., Hay, S. I., Gupta, S., Weatherall, D. J., & Williams, T. N. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001484 · Cited by 1,138 · cited 1×
“The birth prevalence of SCD in Tanzania is 6 per 1,000 live births, ranking Tanzania as the fourth country in the world (after Nigeria, Democratic Republic of Congo (DRC) and India) with the highest number of SCD births [13].”
BackgroundProtective effects of the sickle cell gene against malaria morbidity and mortality
Aidoo, M., Terlouw, D. J., Kolczak, M. S., McElroy, P. D., ter Kuile, F. O., Kariuki, S., Nahlen, B. L., Lal, A. A., & Udhayakumar, V. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08273-9 · Cited by 700 · cited 2×
“For HbS, we confirmed previous observations [1,2] that the prevalence of malaria in individuals with HbAS and HbSS was lower compared to those with HbAA.”
BackgroundResultTHE RATE OF MUTATION OF HUMAN GENES
HALDANE, J. B. S. (2010) · Hereditas · doi:10.1111/j.1601-5223.1949.tb03339.x · Cited by 386 · cited 1×
“The malaria hypothesis proposes that areas with high malaria transmission will have a high prevalence of malaria-protective haemoglobin variants [9].”
Background(2019) · The Statesman’s Yearbook Companion · doi:10.1057/978-1-349-95839-9_994 · Cited by 340
Mortality in Sickle Cell Anemia in Africa: A Prospective Cohort Study in Tanzania
Makani, J., Cox, S. E., Soka, D., Komba, A. N., Oruo, J., Mwamtemi, H., Magesa, P., Rwezaula, S., Meda, E., Mgaya, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014699 · Cited by 326 · cited 1×
“The study included individuals seen at MNH between March 2004 and December 2013 within the framework of the Muhimbili Sickle Cell (MSC) programme which has been previously described [3,14].”
MethodSelf-citationWilliams, T. N., Mwangi, T. W., Wambua, S., Peto, T. E. A., Weatherall, D. J., Gupta, S., Recker, M., Penman, B. S., Uyoga, S., Macharia, A., et al. (2005) · Nature Genetics · doi:10.1038/ng1660 · Cited by 247 · cited 1×
“Negative epistasis has been reported between sickle hemoglobin and α-thalassaemia, where their co-existence results in the loss of the malaria protection effect of either Hb variant [10].”
BackgroundSelf-citationOxidant damage mediates variant red cell resistance to malaria
FRIEDMAN, M. J. (1979) · Nature · doi:10.1038/280245a0 · Cited by 234 · cited 1×
“However, one of the recent studies associated HbF with impairment of binding of parasitized red blood cells to human microvascular endothelial cells, monocytes and nonparasitized erythrocytes [17].”
Cited by
Fetal hemoglobin in sickle cell anemia
Steinberg, M. H. (2020) · Blood · doi:10.1182/blood.2020007645 · Cited by 136
Evolutionary history of sickle-cell mutation: implications for global genetic medicine
Esoh, K. K., & Wonkam, A. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab004 · Cited by 103
“interest in a possible epistatic interaction between variants in the HbF-promoting loci and the HBB-βS variant, among individual living in malaria- endemic regions in Tanzania (48).”
BackgroundTluway, F. D., & Makani, J. (2017) · British Journal of Haematology · doi:10.1111/bjh.14594 · Cited by 102
“The programme conducted the first genome-wide association study to identify new variants (Mtatiro et al, 2014) and also participated in multi-centre studies to further elucidate these genetic loci (Menzel et al, 2014; Mtatiro et al, 2015a).”
Self-citationThe genomic landscape of African populations in health and disease
Rotimi, C. N., Bentley, A. R., Doumatey, A. P., Chen, G., Shriner, D., & Adeyemo, A. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx253 · Cited by 92
A ten year review of the sickle cell program in Muhimbili National Hospital, Tanzania
Makani, J., Tluway, F. D., Makubi, A. N., Soka, D., Nkya, S. W., Sangeda, R. Z., Mgaya, J., Rwezaula, S. S., Kirkham, F. J., Kindole, C., et al. (2018) · BMC Hematology · doi:10.1186/s12878-018-0125-0 · Cited by 72
Self-citationHemoglobin E, malaria and natural selection
Ha, J., Martinson, R., Iwamoto, S. K., & Nishi, A. (2019) · Evolution Medicine and Public Health · doi:10.1093/emph/eoz034 · Cited by 29
“One epidemiological study suggested negative epistasis between HbF and HbS on malaria [103].”
BackgroundLwanira, C. N., Kironde, F., Kaddumukasa, M., & Swedberg, G. (2017) · Malaria Journal · doi:10.1186/s12936-017-1970-1 · Cited by 21
Mnika, K., Pule, G. D., Dandara, C., & Wonkam, A. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0105 · Cited by 19
“…hydroxyurea (HU) more frequently (Makubi et al., 2012; Olabode and Shokunbi, 2006; Ware, 2013), and to initiate genetic studies (Cox et al., 2014; Mmbando et al., 2015; Mtatiro et al., 2014; Pule et al., 2015; Rumaney et al., 2014; Wonkam et al., 2014a, 2014b, 2014c), there is still a lack of…”
David, S., Aguiar, P. M. V., Antunes, L., Dias, A., Morais, A., Sakuntabhai, A., & Lavinha, J. (2017) · Immunogenetics · doi:10.1007/s00251-017-1013-7 · Cited by 13
Purohit, P. (2016) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2016.055 · Cited by 10
“In general, hydroxyurea must be started in severe patients with SCA because (1) increasing HbF level following hydroxyurea therapy is the principal but not the sole determinant of clinical responses in these patients; (2) some patients with minimal or no increased in HbF level following hydroxyurea therapy also showed…”
Human genetic variations conferring resistance to malaria
Zhang, X., Wu, J., Peng, Y., Luo, L., Zhang, L., Huang, X. X., Chen, G., Li, Y., & Yi, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07017-w · Cited by 11
“Studies have found that increased HbF levels are associated with reduced malaria risk [84], but G. Pasvol et.al confirmed through studies using mixtures of HbF and HbA dominant RBCs that P.f invasion is not affected by the presence of HbF, but rather by the age of the RBCs [85], possibly due to HbF…”
Gbaguidi, M. L. E., Adamou, R., Edslev, S. M., Hansen, A., Domingo, N. D., Dechavanne, C., Massougbodji, A., Garcia, A., Theisen, M., Milet, J., et al. (2024) · Malaria Journal · doi:10.1186/s12936-024-04970-7 · Cited by 9
“The lack of evidence of a protective maternal Abs in infancy can be explained by the use of ITNs [73, 74] and fetal hemoglobin [75, 76].”
BackgroundHolla, P., Bhardwaj, J., & Tran, T. M. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230401 · Cited by 5
F‐erythrocytes promote Plasmodium falciparum proliferation in sickle cell disease
Archer, N. M., Gnangnon, B., Mikdar, M., Ciuculescu, M. F., Petersen, N., Staffa, S. J., & Duraisingh, M. T. (2023) · American Journal of Hematology · doi:10.1002/ajh.27042 · Cited by 3
Zhang, Q., Li, J., Huang, H., Shang, X., Ye, Y., Zhang, W., Lin, P., Gong, Y., Hoh, B., Luo, Q., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65019-0 · Cited by 3
“Previous studies have highlighted complex interactions between HbF levels and malaria susceptibility 59,60 , but the speci fi c evolutionary forces underlying the HG2 distribution remain unclear and merit further investigation.”
Does fetal hemoglobin inhibit the malarial parasite Plasmodium falciparum?
Archer, N. M., Pasvol, G., Wilson, I., & Duraisingh, M. T. (2022) · American Journal of Hematology · doi:10.1002/ajh.26661 · Cited by 2
Chiopris, G., Maccario, S., Artaiga, T. H. E., Mohamed, A. I., Valenti, M., & Esposito, S. (2021) · Pathogens · doi:10.3390/pathogens10080985 · Cited by 2
“showed a negative epistasis between HbS and HbF and a reduction in protection against malaria [19].”
BackgroundPaasi, G., Namazzi, R., Asiimwe, G., Ndeezi, G., Rujumba, J., Sekaggya‐Wiltshire, C., Mupere, E., Munabi, I. G., Kiguli, S., Idro, R., et al. (2026) · Anemia · doi:10.1155/anem/9928766 · Cited by 1
Masamu, U., Sangeda, R. Z., Mgaya, J., Nkya, S. W., Octavian, B., Mtiiye, F. R., Nduguru, J., Jonathan, A., Kandonga, D., Minja, I. K., et al. (2023) · Biopreservation and Biobanking · doi:10.1089/bio.2023.0060 · Cited by 1
Self-citationInsights into the Genomic Landscape of African Ancestry Populations
Rotimi, C. N., Bentley, A. R., Doumatey, A. P., Chen, G., Shriner, D., & Adeyemo, A. (2021) · Wiley eBooks · doi:10.1002/9781119374855.ch9
Gbaguidi, M. L. E., Adamou, R., Edslev, S., Hansen, A., Domingo, N. D., Dechavanne, C., Massougbodji, A., Garcia, A., Theisen, M., Milet, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25857529
Gbaguidi, M. L. E., Adamou, R., Edslev, S., Hansen, A., Domingo, N. D., Dechavanne, C., Massougbodji, A., Garcia, A., Theisen, M., Milet, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25857587
SANTOS, B. M. D. A. F. D. (2024) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Perspective Chapter: Fetal Hemoglobin Modulators
Walke, V. A. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1017037
Metadata
- Authors
- Mmbando, B. P., Mgaya, J., Cox, S. E., Mtatiro, S. N., Soka, D., Rwezaula, S., Meda, E., Msaki, E., Snow, R. W., Jeffries, N., Geller, N. L., & Makani, J.
- Affiliations
- Muhimbili University of Health and Allied Sciences (TZ)
- Muhimbili National Hospital (TZ)
- Kenya Medical Research Institute (KE)
- National Institutes of Health (US)
- Corresponding author
- Mmbando, Bruno P.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-05-12
- Volume
- 10
- Issue
- 5
- Pages
- e0125929
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4428884
- OpenAlex
- W1824394008
- Semantic Scholar
- bc5f2cbabc24fdefbf4c9a247f6a846a7b9c06be
- Cited by
- 23
- References
- 23
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 4 · 2016: 3
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- IHI Repository (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Wellcome Trust (084538, 079080 &, 103602/Z/14/Z, H3Africa, 092654, 103602, 095009, 079080, 093727, 080025)
- Muhimbili University of Health and Allied Sciences
- University of Health and Allied Sciences
- National Institutes of Health
- National Human Genome Research Institute (U41HG006941)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- sickle cell disease, hemoglobin S, fetal hemoglobin, negative epistasis, malaria prevention, hemoglobin variants, sickle cell trait, HbSS, malaria prevalence, Tanzania, Muhimbili National Hospital, malaria risk factors
- MeSH terms
- Adolescent, Adult, Aged, Anemia, Sickle Cell, Child, Child, Preschool, Epistasis, Genetic, Female, Fetal Hemoglobin, Hemoglobin, Sickle, Humans, Infant, Infant, Newborn, Malaria, Male, Middle Aged, Tanzania, Logistic Models, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.